These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ["E" and "EAC" rosette tests of peripheral blood in children with Down's syndrome]. Kobielowa Z; Pietrzyk J; Mytar B; Mitkowska Z Pediatr Pol; 1980 May; 55(5):609-15. PubMed ID: 6447268 [No Abstract] [Full Text] [Related]
4. [Humoral and cellular immunity in children with Down's syndrome]. Lukas A; Cesarz E; Lukas W; Sychłowy A; Sliwa F Pediatr Pol; 1980 Jan; 55(1):33-40. PubMed ID: 6445054 [No Abstract] [Full Text] [Related]
5. T system immune-deficiency in Down's syndrome. Levin S; Nir E; Mogilner BM Pediatrics; 1975 Jul; 56(1):123-6. PubMed ID: 125869 [No Abstract] [Full Text] [Related]
6. Down's syndrome as a model disease. Scoggin CH; Patterson D Arch Intern Med; 1982 Mar; 142(3):462-4. PubMed ID: 6461305 [TBL] [Abstract][Full Text] [Related]
7. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome]. Bartelik S Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies to thymocytes in the serum of Down's syndrome patients]. Domashneva IV; Shvarts EI; Kushner SG Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1424-7. PubMed ID: 158926 [No Abstract] [Full Text] [Related]
9. Alopecia areata and vitiligo associated with Down's syndrome. Brown AC; Olkowski ZL; McLaren JR; Kutner MH Arch Dermatol; 1977 Sep; 113(9):1296. PubMed ID: 143244 [No Abstract] [Full Text] [Related]
11. [Cellular immunity tests in children with Down's syndrome]. Szigeti R; Révész T; Schuler D Orv Hetil; 1974 Sep; 115(38):2173-5. PubMed ID: 4277782 [No Abstract] [Full Text] [Related]
12. [Down's syndrome. Precocious aging of the immune system]. Bonetti F; Licastro F; Chiricolo M; Franceschi C Recenti Prog Med; 1980 Dec; 69(6):679-709. PubMed ID: 6454228 [No Abstract] [Full Text] [Related]
13. [Australia antigen in children with Down's syndrome]. Korczowski R Pol Tyg Lek; 1972 Feb; 27(9):327-9. PubMed ID: 4259782 [No Abstract] [Full Text] [Related]
14. Occurrence of hepatitis B surface antigen in patients with Down's syndrome. Yüksel M; Uzunalimoğlu O; Oge G; Demirağ B Turk J Pediatr; 1977; 19(1-2):47-51. PubMed ID: 154756 [No Abstract] [Full Text] [Related]
16. Islet autoimmunity in children with Down's syndrome. Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360 [TBL] [Abstract][Full Text] [Related]
17. Letter: Ageing, T lymphocytes, and Down's syndrome. Burgio GR; Nespoli L Lancet; 1974 Dec; 2(7896):1580. PubMed ID: 4141027 [No Abstract] [Full Text] [Related]
18. [Antigenic treatment of patients with Down's syndrome]. Ruiz-Castañeda M; Gutiérrez de Velásco-Hernández C; Gómez-Ortiz ME; Pillado-Hernández MT Bol Med Hosp Infant Mex; 1982 Dec; 39(12):778-80. PubMed ID: 6220726 [No Abstract] [Full Text] [Related]
19. Induction of asymptomatic HBeAG carrier state in a patient with Down's syndrome following human bite. Kanda T; Hara H; Hanaoka T; Kobayashi I J Med; 1994; 25(6):383-7. PubMed ID: 7769376 [TBL] [Abstract][Full Text] [Related]
20. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D Arch Dis Child; 2004 Nov; 89(11):1014-7. PubMed ID: 15499053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]